137 A phase I study of an oral vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor, CP-547,632, in patients with advanced solid tumors

137 A phase I study of an oral vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor, CP-547,632, in patients with advanced solid tumors

Saved in:
Bibliographic Details
Published in:European journal of cancer supplements Vol. 2; no. 8; p. 44
Main Authors: Tolcher, A., O'Leary, J.J., DeBono, J., Molpus, K., Woodard, C., Warnat, M., Liau, K., Noe, D., Healey, D., Huberman, M.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-09-2004
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(04)80145-9